Skip to content
NOWCAST 비바카지노 Viva News at Noon
Watch on Demand
코인카지노

Third US vaccine could raise question: Which shots are best?

Third US vaccine could raise question: Which shots are best?
MATT: DOCTORS IN BOSTON AND DOCTORS ACROSS THE COUNTRY WILL BE WATCHING WHAT HAPPENS TODAY VERY CAREFULLY. AT 9AM TODAY, AN FDA ADVISORY BOARD IN WASHINGTON WILL OPEN ITS HEARING ON THE JOHNSON & JOHNSON VACCINE AGAINST COVID-19. UNLIKE MODERNA AND PFIZER, THIS IS A ONE DOSE VACCINE. IT ALSO DOES NOT REQUIRE SPECIAL STORAGE. EARLIER THIS WEEK, THE FDA RELEASE ITS ANALYSIS FINDING THE SHOT 72% EFFECTIVE AT PREVENTING SEVERE FORMS OF THE VIRU THE EARLY RESEARCH ON THIS VACCINE WAS DONE AT BETH ISRAE DEACONNESS MEDICAL CENTER AND BRIGHAM AND WOMEN맥스카지노S HOSPITAL. EARLIER THIS WEEK, ONE OF THE LEAD RESEARCHERS TOLD US THIS VACCINE HAS ALSO BEEN SHOWN TO PREVENT TRANSMISSION OF THE VIRUS. >> THE DATA WE HAVE SO FAR SHOWS THAT THIS VACCINE NOT JUST -- PREVENTION OF INFECTION, NOT JUST PREVENTION OF DISEASE. REPORTER: THE OTHER BIG QUESTION HERE, SUPPLY JOHNSON AND JOHNSON SAYS IT맥스카지노S READY TO SHIP 3 TO 4 MILLION DOSES RIGHT AWAY. WITH 20 MILLION BY THE END OF MARCH AND 100 MILLION BY THE END OF JUNE. AUTHORIZATION COULD COME AS EARLY AS TONIG
코인카지노
Third US vaccine could raise question: Which shots are best?
The nation is poised to get a third vaccine against COVID-19, but because at first glance the Johnson & Johnson shot may not be seen as equal to other options, health officials are girding for the question: Which one is best?If cleared for emergency use, the J&J vaccine would offer a one-dose option that could help speed vaccinations, tamp down a pandemic that has killed more than 500,000 people in the U.S. and stay ahead of a mutating virus.맥스카지노I think it맥스카지노s going to be huge,맥스카지노 said Dr. Virginia Caine, director of the public health department in Marion County, Indiana, which includes Indianapolis. She expects the easier-to-use vaccine will give local officials more flexibility for mobile vaccination clinics or pop-up events.The challenge will be explaining how protective the J&J shot is after the astounding success of the first U.S. vaccines.Two doses of the Pfizer and Moderna shots were found to be about 95% effective against symptomatic COVID-19. The numbers from J&J맥스카지노s study are not that high, but they are not an apples-to-apples comparison. One dose of the J&J vaccine was 85% protective against the most severe COVID-19. After adding in moderate cases, the total effectiveness dropped to about 66%.맥스카지노I don맥스카지노t think it맥스카지노s a second-tier vaccine, but we맥스카지노ve got to avoid that perception,맥스카지노 said Dr. Thomas Balcezak of Yale New Haven Health System.The J&J shot was tested in the U.S., Latin America and South Africa at a time when more contagious mutated versions of the virus were spreading. That wasn맥스카지노t the case last fall, when Pfizer and Moderna were wrapping up testing, and it맥스카지노s not clear if their numbers would hold against the most worrisome of those variants.Importantly, the Food and Drug Administration reported this week that, just like its predecessors, the J&J shot offers strong protection against the worst outcomes. By 28 days after the injection, there were no hospitalizations or deaths in study volunteers given the J&J shot, compared with 16 hospitalizations and seven deaths in those given a dummy shot.Independent advisers to the FDA recommended Friday that there's enough evidence to allow widespread use of J&J's vaccine, setting the stage for a final decision within days.If it rolls out next week, U.S. officials expect to have only a few million doses to divide between states in initial shipments. But by the end of March, J&J has said it can supply enough to vaccinate 20 million people 맥스카지노 a much-needed boost to stretched supplies.The bottom line: 맥스카지노Whatever vaccine is being offered is what you want,맥스카지노 said University of Pennsylvania immunologist E. John Wherry.Still, the nuances of the vaccines raise ethical questions.At Yale, Balcezak is struggling with how to make the best use of the J&J shot's advantages without appearing to target it to underserved populations. For example, it맥스카지노s a logical choice for homeless shelters where people may have moved on before their second dose of the Pfizer or Moderna vaccine.맥스카지노I맥스카지노m very worried about how that would be perceived,맥스카지노 Balcezak said. The J&J vaccine is also easier to handle, lasting three months in the refrigerator compared to the Pfizer and Moderna options, which must be frozen.Balcezak said the Yale system has been working with pastors and other 맥스카지노cultural ambassadors맥스카지노 to answer vaccine questions from minority communities, and likewise will discuss the J&J shot's possibilities.In Washington state, health officials see some clear need for one-and-done vaccinations 맥스카지노 including sailors in the maritime industry, who can spend months on cargo and fishing vessels.맥스카지노This is the ideal vaccine for them,맥스카지노 said Dr. Scott Lindquist of the Washington State Department of Health. With the two-dose vaccines, the state 맥스카지노had to send second doses onward to the next port of call.맥스카지노Other parts of the world already are facing which-is-best challenges. AstraZeneca맥스카지노s vaccine, for instance, is cleared for use in Britain and Europe after data suggested it was about 70% effective. Italy맥스카지노s government recently decided to reserve Pfizer and Moderna shots for the elderly and designate the AstraZeneca vaccine for younger, at-risk workers, sparking protest from the country맥스카지노s main teachers맥스카지노 union.In the U.S., health officials say it's critical for the government to send a clear message.맥스카지노Right now, it맥스카지노s not vaccine against vaccine, it맥스카지노s vaccine against virus,맥스카지노 said Dr. Nirav Shah, director of the Maine Center for Disease Control and Prevention.___AP Medical Writer Carla K. Johnson in Seattle contributed to this report.___The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute맥스카지노s Department of Science Education. The AP is solely responsible for all content.

The nation is poised to get a third vaccine against COVID-19, but because at first glance the Johnson & Johnson shot may not be seen as equal to other options, health officials are girding for the question: Which one is best?

If cleared for emergency use, the J&J vaccine would offer a one-dose option that could help speed vaccinations, tamp down a pandemic that has killed more than 500,000 people in the U.S. and stay ahead of a mutating virus.

코인카지노

맥스카지노I think it맥스카지노s going to be huge,맥스카지노 said Dr. Virginia Caine, director of the public health department in Marion County, Indiana, which includes Indianapolis. She expects the easier-to-use vaccine will give local officials more flexibility for mobile vaccination clinics or pop-up events.

The challenge will be explaining how protective the J&J shot is after the astounding success of the first U.S. vaccines.

Two doses of the Pfizer and Moderna shots were found to be about 95% effective against symptomatic COVID-19. The numbers from J&J맥스카지노s study are not that high, but they are not an apples-to-apples comparison. One dose of the J&J vaccine was 85% protective against the most severe COVID-19. After adding in moderate cases, the total effectiveness dropped to about 66%.

맥스카지노I don맥스카지노t think it맥스카지노s a second-tier vaccine, but we맥스카지노ve got to avoid that perception,맥스카지노 said Dr. Thomas Balcezak of Yale New Haven Health System.

The J&J shot was tested in the U.S., Latin America and South Africa at a time when more contagious mutated versions of the virus were spreading. That wasn맥스카지노t the case last fall, when Pfizer and Moderna were wrapping up testing, and it맥스카지노s not clear if their numbers would hold against the most worrisome of those variants.

Importantly, the Food and Drug Administration reported this week that, just like its predecessors, the J&J shot offers strong protection against the worst outcomes. By 28 days after the injection, there were no hospitalizations or deaths in study volunteers given the J&J shot, compared with 16 hospitalizations and seven deaths in those given a dummy shot.

Independent advisers to the FDA recommended Friday that there's enough evidence to allow widespread use of J&J's vaccine, setting the stage for a final decision within days.

If it rolls out next week, U.S. officials expect to have only a few million doses to divide between states in initial shipments. But by the end of March, J&J has said it can supply enough to vaccinate 20 million people 맥스카지노 a much-needed boost to stretched supplies.

The bottom line: 맥스카지노Whatever vaccine is being offered is what you want,맥스카지노 said University of Pennsylvania immunologist E. John Wherry.

Still, the nuances of the vaccines raise ethical questions.

At Yale, Balcezak is struggling with how to make the best use of the J&J shot's advantages without appearing to target it to underserved populations. For example, it맥스카지노s a logical choice for homeless shelters where people may have moved on before their second dose of the Pfizer or Moderna vaccine.

맥스카지노I맥스카지노m very worried about how that would be perceived,맥스카지노 Balcezak said.

The J&J vaccine is also easier to handle, lasting three months in the refrigerator compared to the Pfizer and Moderna options, which must be frozen.

Balcezak said the Yale system has been working with pastors and other 맥스카지노cultural ambassadors맥스카지노 to answer vaccine questions from minority communities, and likewise will discuss the J&J shot's possibilities.

In Washington state, health officials see some clear need for one-and-done vaccinations 맥스카지노 including sailors in the maritime industry, who can spend months on cargo and fishing vessels.

맥스카지노This is the ideal vaccine for them,맥스카지노 said Dr. Scott Lindquist of the Washington State Department of Health. With the two-dose vaccines, the state 맥스카지노had to send second doses onward to the next port of call.맥스카지노

Other parts of the world already are facing which-is-best challenges. AstraZeneca맥스카지노s vaccine, for instance, is cleared for use in Britain and Europe after data suggested it was about 70% effective. Italy맥스카지노s government recently decided to reserve Pfizer and Moderna shots for the elderly and designate the AstraZeneca vaccine for younger, at-risk workers, sparking protest from the country맥스카지노s main teachers맥스카지노 union.

In the U.S., health officials say it's critical for the government to send a clear message.

맥스카지노Right now, it맥스카지노s not vaccine against vaccine, it맥스카지노s vaccine against virus,맥스카지노 said Dr. Nirav Shah, director of the Maine Center for Disease Control and Prevention.

___

AP Medical Writer Carla K. Johnson in Seattle contributed to this report.

___

The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute맥스카지노s Department of Science Education. The AP is solely responsible for all content.